Bulevirtide, also known by its developmental code name Myrcludex B, is a synthetic lipopeptide inhibitor of the sodium taurocholate cotransporting polypeptide (NTCP) that effectively inhibits the cellular entry of both hepatitis B virus (HBV) and hepatitis D virus (HDV) into hepatocytes, even in cases of compensated cirrhosis, showing significant potential for the treatment of chronic hepatitis D.
Molecular Weight:
5398.86
CAS Number:
[2012558-47-1]
Formula:
C248H355N65O72
Target:
HBV
T35373
T35373
* VAT and and shipping costs not included. Errors and price changes excepted